These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22686519)

  • 1. Red blood cell transfusion risks in patients with end-stage renal disease.
    Tanhehco YC; Berns JS
    Semin Dial; 2012; 25(5):539-44. PubMed ID: 22686519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion.
    Collins AJ; Monda KL; Molony JT; Li S; Gilbertson DT; Bradbury BD
    Am J Kidney Dis; 2014 Jun; 63(6):997-1006. PubMed ID: 24315770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cell (RBC) transfusion rates among US chronic dialysis patients during changes to Medicare end-stage renal disease (ESRD) reimbursement systems and erythropoiesis stimulating agent (ESA) labels.
    Cappell KA; Shreay S; Cao Z; Varker HV; Paoli CJ; Gitlin M
    BMC Nephrol; 2014 Jul; 15():116. PubMed ID: 25015348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL.
    Gilbertson DT; Monda KL; Bradbury BD; Collins AJ
    Am J Kidney Dis; 2013 Nov; 62(5):919-28. PubMed ID: 23815986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: a retrospective cohort analysis.
    Wetmore JB; Peng Y; Monda KL; Kats AM; Kim DH; Bradbury BD; Collins AJ; Gilbertson DT
    Am J Nephrol; 2015; 41(4-5):354-61. PubMed ID: 26107376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost implications to Medicare of recombinant erythropoietin therapy for the anemia of end-stage renal disease.
    Powe NR; Griffiths RI; Bass EB
    J Am Soc Nephrol; 1993 Apr; 3(10):1660-71. PubMed ID: 8318682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of changes in adult erythropoietin dosing guidelines on erythropoietin dosing practices, anemia, and blood transfusion in children on hemodialysis: findings from North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS).
    Twichell SA; Hunt EAK; Martz K; Somers MJG;
    Pediatr Nephrol; 2020 Feb; 35(2):297-303. PubMed ID: 31709464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient.
    Mattison P; Upadhyay K; Wilcox JE; Moudgil A; Silverstein DM
    Pediatr Nephrol; 2010 May; 25(5):971-6. PubMed ID: 20091055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
    Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Shapiro MJ; Corwin MJ; Colton T;
    JAMA; 2002 Dec; 288(22):2827-35. PubMed ID: 12472324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resurgence of blood transfusion therapy in erythropoietin treated hemodialysis patients.
    Ifudu O; Macey LJ; Friedman EA
    ASAIO J; 1995; 41(3):M426-30. PubMed ID: 8573839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis patients' preferences for the management of anemia.
    Hauber B; Caloyeras J; Posner J; Brommage D; Tzivelekis S; Pollock A
    BMC Nephrol; 2017 Jul; 18(1):253. PubMed ID: 28750609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical factors influencing the decision to order red blood cell transfusions for a sample of US dialysis patients
.
    Stephens JM; Caloyeras JP; Holmen J; Kumar VA; Tzivelekis S; Pollock A
    Clin Nephrol; 2017 Apr; 87 (2017)(4):180-187. PubMed ID: 28211787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the prospective payment system on anemia management in maintenance dialysis patients: implications for cost and site of care.
    Wetmore JB; Tzivelekis S; Collins AJ; Solid CA
    BMC Nephrol; 2016 May; 17(1):53. PubMed ID: 27228981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of erythropoietin versus blood transfusions for cervical cancer patients receiving chemoradiotherapy.
    Kavanagh BD; Fischer BA; Segreti EM; Wheelock JB; Boardman C; Roseff SD; Cardinale RM; Benedict SH; Goram AL
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):435-41. PubMed ID: 11567818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities.
    House AA; Pham B; Pagé DE
    Nephrol Dial Transplant; 1998 Jul; 13(7):1763-9. PubMed ID: 9681725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic syndrome: the other cause of anemia in end-stage renal disease patients undergoing dialysis.
    Chang MY; Lin SF; Wu SC; Yang WC
    Sci Rep; 2020 Sep; 10(1):15557. PubMed ID: 32968161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of nocturnal home hemodialysis on anemia management in patients with end-stage renal disease.
    Schwartz DI; Pierratos A; Richardson RM; Fenton SS; Chan CT
    Clin Nephrol; 2005 Mar; 63(3):202-8. PubMed ID: 15786821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of erythropoiesis-stimulating agents on red blood cell transfusion in Korea.
    Kang RY; Lee J; Lee YH; Lee HS; Jeong JH; Lee YJ
    Int J Clin Pharm; 2012 Aug; 34(4):651-7. PubMed ID: 22729393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a standardized transfusion ratio as a metric for evaluating dialysis facility anemia management practices.
    Liu J; Li S; Gilbertson DT; Monda KL; Bradbury BD; Collins AJ
    Am J Kidney Dis; 2014 Oct; 64(4):608-15. PubMed ID: 24820317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.